The new Shareholder list at RLS Global AB

RLS Global AB completed a directed new share issue raising proceeds of SEK 50 million as of 25th of September. It is very encouraging that RLS has engaged national- and international institutions to establish a long-term foundation for the company, says Karin Fischer, CEO RLS Global.

The new shareholder list can be found at RLS Global website: https://rls.global/investor/financial-information/list-of-owners-2/

For more information, please contact:

Karin Fischer, CEO
Phone. +46 70 248 46 51
karin.fischer@rlsglobal.se

Eva Jagenheim, CFO
Phone. +46 31 780 68 20
eva.jagenheim@rlsglobal.se

About RLS Global
For many years, RLS Global has worked with oral care specialists, pioneering new therapies for oral care patients. We have now taken another major step toward easier and more effective wound care. We will continue to work with healthcare professionals to develop treatment that helps deliver the best care for each patient. The method is clinically proven and saves the patient a great deal of suffering. Our focus is on caring for patients, developing safe and efficient products that offer gentle treatment methods. We are proud to provide minimally invasive therapy, improving quality of life for patients worldwide. Certified Adviser is Erik Penser Bank, telephone +46 8 463 83 00, Email: certifiedadviser@penser.se. Read more at www.rls.global  

About Us

For many years, RLS Global has worked with Oral Care specialists, pioneering new therapies for Oral Care and their patients. We are now taking another major step toward easier and more effective care within Wound Care. We will continue to work with Health care Professionals to ensure to develop a treatment that further helps deliver the best care for each patient. The method is clinically proven and saves the patient a lot of suffering. Our focus is on caring for the patients, developing efficient and safe products that offer gentle treatment methods. We’re proud to provide Minimally Invasive Therapy which provides Quality of Life for patients worldwide.